STAMP+CBT application for Chronic Pain

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
Dana-Farber at Merrimack Valley, Methuen, MA
Chronic Pain+5 More
STAMP+CBT application - Behavioral
Eligibility
18+
All Sexes
What conditions do you have?
Select

Study Summary

The purpose of this study is to test whether a mobile application developed to help people with cancer pain is useful and helpful to patients with cancer.

Eligible Conditions

  • Chronic Pain
  • Active Cancer Treatment
  • Cancer, Advanced
  • Malignant Neoplasms
  • Active Cancer
  • Palliative Care

Treatment Effectiveness

Effectiveness Progress

1 of 3

Study Objectives

2 Primary · 3 Secondary · Reporting Duration: 6 Months

4 Weeks
Overall Intervention Adherence Rate
4 weeks
Acceptability Rate
6 Months
Study Accrual Rate
Study retention
6 Weeks
COMPREHENSIVE ENDPOINT

Trial Safety

Trial Design

1 Treatment Group

STAMP+CBT PILOT
1 of 1
Experimental Treatment

15 Total Participants · 1 Treatment Group

Primary Treatment: STAMP+CBT application · No Placebo Group · N/A

STAMP+CBT PILOT
Behavioral
Experimental Group · 1 Intervention: STAMP+CBT application · Intervention Types: Behavioral

Trial Logistics

Trial Timeline

Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: 6 months
Closest Location: Dana-Farber at Merrimack Valley · Methuen, MA
Photo of massachusetts 1Photo of massachusetts 2Photo of massachusetts 3
N/AFirst Recorded Clinical Trial
1 TrialsResearching Chronic Pain
0 CompletedClinical Trials

Who is running the clinical trial?

National Palliative Care Research Center (NPCRC)UNKNOWN
1 Previous Clinical Trials
62 Total Patients Enrolled
Dana-Farber Cancer InstituteLead Sponsor
1,008 Previous Clinical Trials
393,031 Total Patients Enrolled
1 Trials studying Chronic Pain
47 Patients Enrolled for Chronic Pain
Desiree Azizoddin, PsyDPrincipal InvestigatorDana-Farber Cancer Institute

Eligibility Criteria

Age 18+ · All Participants · 8 Total Inclusion Criteria

Mark “yes” if the following statements are true for you:
You have chronic pain related to cancer or treatment.
You have an active prescription for at least one opioid medication to treat your cancer pain.
You are willing to use an android device provided by the study team.

About The Reviewer

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 9th, 2021

Last Reviewed: August 12th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.